Omeros Corp. (OMER)
12.49
-0.96
(-7.14%)
USD |
NASDAQ |
Jan 09, 16:00
12.54
+0.05
(+0.40%)
After-Hours: 20:00
Omeros Research and Development Expense (Annual): 119.52M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.823B |
| Johnson & Johnson | 17.26B |
| Eli Lilly & Co. | 10.99B |
| Edgewise Therapeutics, Inc. | 124.90M |
| GeoVax Labs, Inc. | 23.71M |